Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction

Bioorganic & Medicinal Chemistry Letters
2018.0

Abstract

Neuronal voltage-gated potassium channels, KV7s, are the molecular mediators of the M current and regulate membrane excitability in the central and peripheral neuronal systems. Herein, we report novel small molecule KV7 openers that demonstrate anti-seizure activities in electroshock and pentylenetetrazol-induced seizure models without influencing Rotarod readouts in mice. The anti-seizure activity was determined to be proportional to the unbound concentration in the brain. KV7 channels are also expressed in the bladder smooth muscle (detrusor) and activation of these channels may cause localized undesired effects. Therefore, the impact of individual KV7 isoforms was investigated in human detrusor tissue using a panel of KV7 openers with distinct activity profiles among KV7 isoforms. KCNQ4 and KCNQ5 mRNA were highly expressed in detrusor tissue, yet a compound that has significantly reduced activity on homomeric KV7.4 did not reduce detrusor contraction. This may suggest that the homomeric KV7.4 channel plays a less significant role in bladder contraction and further investigation is needed.

Knowledge Graph

Similar Paper

Novel KV7 ion channel openers for the treatment of epilepsy and implications for detrusor tissue contraction
Bioorganic & Medicinal Chemistry Letters 2018.0
Discovery of a novel Kv7 channel opener as a treatment for epilepsy
Bioorganic & Medicinal Chemistry Letters 2015.0
Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators
European Journal of Medicinal Chemistry 2011.0
Design, synthesis and evaluation of novel N-phenylbutanamide derivatives as KCNQ openers for the treatment of epilepsy
Bioorganic & Medicinal Chemistry Letters 2018.0
Design, synthesis and evaluation of substituted piperidine based KCNQ openers as novel antiepileptic agents
Bioorganic & Medicinal Chemistry Letters 2018.0
Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved Specificity
ACS Medicinal Chemistry Letters 2019.0
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators
Journal of Medicinal Chemistry 2020.0
Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators
Bioorganic & Medicinal Chemistry Letters 2019.0
K<sub>v</sub>7 (KCNQ) Channel Modulators and Neuropathic Pain
Journal of Medicinal Chemistry 2007.0
Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity
Journal of Medicinal Chemistry 2022.0